ConcertAI and NeoGenomics Announce Collaboration to Advance Population-Scale, Definitive Hematological Research & Generative AI Solutions at 2024 JP Morgan Conference

CAMBRIDGE, Mass., Jan. 8, 2024 /PRNewswire/ — ConcertAI, LLC, a leading oncology real-world evidence data and AI technology company, and NeoGenomics, Inc., a leading oncology testing services company, today announced a broad...